Accurate identification of anaerobic bacteria is essential for understanding their clinical significance and supporting appropriate patient management. Although matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) has significantly improved identification in clinical microbiology laboratories, some anaerobes remain difficult to identify reliably.
In her presentation, Kathleen Boiten, PhD researcher at the Dutch Expertise Laboratory for Anaerobic Bacteria at University Medical Center Groningen, The Netherlands, explored the factors influencing identification accuracy and how collaborative database development is helping laboratories identify a wider range of anaerobic species.
At a glance
- MALDI-TOF MS can identify anaerobic bacteria more reliably and efficiently than conventional phenotypic methods.
- Identification accuracy depends on factors including sample preparation, handling and database coverage.
- The ENRIA project improved identification rates by expanding reference data for commonly encountered anaerobes.
- ENRIA 2 is addressing gaps for uncommon and underrepresented species.
- Identification using MALDI-TOF MS can improve understanding of anaerobic infections and support further clinical investigation.
Why accurate identification matters
Identifying anaerobic bacteria using conventional phenotypic methods can be time-consuming and challenging. MALDI-TOF MS has improved both the speed and breadth of identification by comparing a bacterial protein spectrum against reference profiles held in a database.
One study compared more than 900 anaerobic isolates using conventional techniques and MALDI-TOF MS. Conventional methods identified almost 58% of the isolates, compared with approximately 95% using MALDI-TOF MS. The results demonstrate the significant improvement this technology can offer, helping laboratories recognise a greater diversity of anaerobic bacteria.
However, MALDI-TOF MS does not guarantee an identification in every case. Its performance depends on the quality of the sample and, crucially, whether the reference database contains sufficient information to recognise the organism.
What influences MALDI-TOF MS identification?
Several practical factors can affect the reliability of results. These include how much bacterial material is applied to the target, the type of colony being sampled, the experience of the person performing the analysis and the extraction method used.
Kathleen highlighted that some anaerobes can be more difficult to prepare than others. For example, the dry colony characteristics of certain Actinomyces species can make it difficult to transfer a consistent amount of material onto the target.
Sample handling can also influence results. Research discussed in the presentation found that many anaerobes could still be identified after exposure to oxygen, but this was not true for every species. Identification became less reliable for Fusobacterium necrophorum after 24 hours exposed to oxygen, while Prevotella intermedia and Actinomyces graevenitzii also showed limitations after longer periods.
Thus, appropriate handling of oxygen-sensitive organisms is important. Even when identification is achieved, preserving bacterial viability is essential if further investigation is required.
Nevertheless, Kathleen emphasised that database coverage is one of the most significant factors determining whether an isolate can be identified reliably.
Expanding database coverage: the ENRIA project
When MALDI-TOF MS was first being adopted for the identification of anaerobes, database limitations left many isolates unidentified. To address this, the European Network for the Rapid Identification of Anaerobes (ENRIA) brought together expertise laboratories and collaborated with Bruker (manufacturer of the MALDI Biotyper instrument) to expand the reference database.
The project collected approximately 650 strains representing 258 species. The aim was to improve coverage of commonly encountered anaerobes, with multiple isolates included for each species to account for variation within species.
The expanded database was subsequently evaluated by six collaborating expert laboratories using more than 6,000 anaerobic strains. Identification increased from 71% with the original database to 79% with the addition of the ENRIA reference data.
Although this represented a clear improvement, it also demonstrated that further work was needed. Commercial databases continue to be updated, and subsequent research has reported higher identification rates. One study involving more than 4,000 anaerobic isolates achieved reliable species-level identification for 95.7% of isolates.
However, uncommon species missing from, or poorly represented in, a database can still present difficulties. A result may be incorrect at species level when the genus is identified correctly, underlining the importance of distinguishing between a reliable genus-level identification and a reliable species-level result.
ENRIA 2: addressing uncommon anaerobes
To tackle the remaining gaps, the team developed ENRIA 2, focusing on uncommon species that are absent from commercial databases or represented by fewer than five reference spectra.
The process begins with a clinical isolate that cannot be identified reliably by MALDI-TOF MS. The team first confirms the identification problem, then uses 16S rRNA gene sequencing to establish the organism’s identity. This information supports the creation of a new reference profile, known as a main spectrum profile (MSP).
The profile is generated through protein extraction and repeated measurements, followed by manual quality assessment of the resulting spectra. Once sufficient high-quality spectra are available, the new MSP can be checked against other databases before being added to the collection.
At the time of the presentation, ENRIA 2 contained 182 MSPs covering 112 species. Of these species, 71% were not represented in the Bruker database, meaning they could not be identified using that database alone.
The project illustrates how collaboration between specialist laboratories can address gaps that individual laboratories may struggle to resolve independently. By adding reliable reference data for less common organisms, ENRIA 2 aims to improve identification beyond the species most frequently encountered in routine practice.
The wider clinical significance
Improved identification is not simply a technical achievement. Recognising a broader range of anaerobic bacteria can help laboratories build a more complete picture of the organisms associated with clinical infections.
MALDI-TOF MS has helped reveal bacterial diversity that may previously have gone undetected or been grouped under broader identifications. More accurate species-level identification can also support further investigation into an organism’s clinical relevance, including research into antimicrobial resistance.
Kathleen also discussed how MALDI-TOF MS can contribute to investigations beyond routine species identification, including work exploring differences between Bacteroides fragilis isolates. Such applications demonstrate the value of reliable identification as a foundation for more detailed microbiological research.
Ultimately, the technology’s effectiveness depends on continued development. Careful sample preparation, appropriate handling, expert interpretation and comprehensive reference databases all contribute to obtaining meaningful results. Projects such as ENRIA and ENRIA 2 show how ongoing collaboration and database expansion can help laboratories overcome persistent identification challenges.
Key Takeaways
- MALDI-TOF MS can substantially improve anaerobic identification compared with conventional phenotypic methods.
- Sample preparation, oxygen exposure and operator experience can influence identification reliability.
- Database coverage remains a key limitation, particularly for uncommon or underrepresented species.
- ENRIA improved identification rates by expanding reference data for commonly encountered anaerobes.
- ENRIA 2 continues this work, adding reference profiles for species missing from commercial databases.
- Continued database development is essential to improving the accuracy and clinical value of anaerobic identification.
Watch the Webinar On-Demand
Watch Kathleen Boiten’s full presentation to learn more about the challenges of identifying anaerobic bacteria and the ongoing work to improve MALDI-TOF MS database coverage here.
en


England